-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
, a few days ago, the launch of new achievements of human source III. type collagen research and the signing ceremony of industrial, academic and research were held in Taiyuan. At the meeting, Shanxi Jinbo Biopharmaceutical Co., Ltd. and the Chinese Academy of Sciences, Fudan University and other units signed a technical cooperation agreement.
it is understood that the research results of human source III. type collagen research are innovative achievements developed by Shanxi Jinbo Biopharmaceutical Co., Ltd. in cooperation with Fudan University School of Basic Medicine and institute of biophysics of the Chinese Academy of Sciences after more than ten years. Human source III. type collagen is the use of biotechnology, based on human source III. type collagen highly active functional area of the gene sequence to build it, combined with protein engineering cutting-edge protein rational design and optimization technology, the results of highly active human source III. type collagen.At the
press conference, researchers from Fudan University's School of Basic Medicine reported and elaborated in detail on the basic research of human origin III. type collagen; Zhu Wei, an associate researcher at the Institute of Biophysics of the Chinese Academy of Sciences, reported on the analysis of the atomic structure of the central functional region of human tissue in the International Protein Database (PDB) numbers 6A0A and 6A0C;
in order to realize the integration of "production, learning and research" and promote the industrialization of this achievement, the human collagen industrial park project has been settled in Shanxi transformation comprehensive reform demonstration area. According to Zhang Jinwang, deputy secretary-general of Shanxi Provincial People's Government and director of the demonstration district management committee, the total investment in the first phase of the project is 820 million yuan, and large-scale production is expected to be realized by 2020, with the output value expected to be more than 10 billion yuan after all production
